Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases.
ALS (amyotrophic lateral sclerosis)
Alzheimer’s
Huntington and Parkinson diseases
calcium
neuroprotection
synapse
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2019
2019
Historique:
received:
23
05
2019
accepted:
31
07
2019
entrez:
26
9
2019
pubmed:
26
9
2019
medline:
26
9
2019
Statut:
epublish
Résumé
Sigma-1 receptor (S1R) is a multi-functional, ligand-operated protein situated in endoplasmic reticulum (ER) membranes and changes in its function and/or expression have been associated with various neurological disorders including amyotrophic lateral sclerosis/frontotemporal dementia, Alzheimer's (AD) and Huntington's diseases (HD). S1R agonists are broadly neuroprotective and this is achieved through a diversity of S1R-mediated signaling functions that are generally pro-survival and anti-apoptotic; yet, relatively little is known regarding the exact mechanisms of receptor functioning at the molecular level. This review summarizes therapeutically relevant mechanisms by which S1R modulates neurophysiology and implements neuroprotective functions in neurodegenerative diseases. These mechanisms are diverse due to the fact that S1R can bind to and modulate a large range of client proteins, including many ion channels in both ER and plasma membranes. We summarize the effect of S1R on its interaction partners and consider some of the cell type- and disease-specific aspects of these actions. Besides direct protein interactions in the endoplasmic reticulum, S1R is likely to function at the cellular/interorganellar level by altering the activity of several plasmalemmal ion channels through control of trafficking, which may help to reduce excitotoxicity. Moreover, S1R is situated in lipid rafts where it binds cholesterol and regulates lipid and protein trafficking and calcium flux at the mitochondrial-associated membrane (MAM) domain. This may have important implications for MAM stability and function in neurodegenerative diseases as well as cellular bioenergetics. We also summarize the structural and biochemical features of S1R proposed to underlie its activity. In conclusion, S1R is incredibly versatile in its ability to foster neuronal homeostasis in the context of several neurodegenerative disorders.
Identifiants
pubmed: 31551669
doi: 10.3389/fnins.2019.00862
pmc: PMC6736580
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
862Subventions
Organisme : NINDS NIH HHS
ID : F32 NS093786
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS056224
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG055577
Pays : United States
Références
FEBS Lett. 1999 Feb 19;445(1):19-22
pubmed: 10069366
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8196-9
pubmed: 10393971
J Pharmacol Exp Ther. 2000 Jun;293(3):788-98
pubmed: 10869377
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):491-6
pubmed: 11149946
Neuron. 2001 Jan;29(1):243-54
pubmed: 11182095
Neuron. 2002 Apr 25;34(3):399-410
pubmed: 11988171
J Neurophysiol. 2002 Jun;87(6):2867-79
pubmed: 12037190
J Pharmacol Exp Ther. 2003 Aug;306(2):718-25
pubmed: 12730355
Neuron. 2003 Jul 17;39(2):227-39
pubmed: 12873381
Eur J Neurosci. 2003 Oct;18(8):2188-96
pubmed: 14622179
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jul;28(4):677-85
pubmed: 15276693
J Pharmacol Exp Ther. 1992 Apr;261(1):123-30
pubmed: 1532832
Proc Natl Acad Sci U S A. 2004 Oct 12;101(41):14949-54
pubmed: 15466698
Pharmacopsychiatry. 2004 Nov;37 Suppl 3:S208-13
pubmed: 15547787
Neurosci Lett. 2005 Jul 1-8;382(1-2):134-8
pubmed: 15911136
Life Sci. 2005 Aug 19;77(14):1612-24
pubmed: 16002098
Acta Neurol Scand. 2005 Aug;112(2):103-7
pubmed: 16008536
Am J Geriatr Psychiatry. 2005 Dec;13(12):1062-6
pubmed: 16319298
Curr Opin Neurobiol. 2006 Feb;16(1):95-101
pubmed: 16361095
Cell. 2005 Dec 29;123(7):1241-53
pubmed: 16377565
J Pharmacol Exp Ther. 2006 May;317(2):606-14
pubmed: 16397090
Neuron. 2006 Mar 2;49(5):671-82
pubmed: 16504943
J Pharmacol Exp Ther. 1991 Nov;259(2):543-50
pubmed: 1658302
Neurodegener Dis. 2005;2(1):6-15
pubmed: 16908998
Pharmacol Biochem Behav. 2006 Aug;84(4):581-97
pubmed: 16945406
Cell. 2006 Sep 8;126(5):981-93
pubmed: 16959576
J Physiol. 2007 Jan 1;578(Pt 1):143-57
pubmed: 17068104
Biochemistry. 2007 Mar 20;46(11):3532-42
pubmed: 17315983
J Clin Invest. 2007 May;117(5):1230-9
pubmed: 17431506
Dement Geriatr Cogn Disord. 2007;23(6):432-8
pubmed: 17457031
Curr Opin Neurobiol. 2007 Jun;17(3):381-6
pubmed: 17498943
Neuropharmacology. 2007 Jul;53(1):125-33
pubmed: 17553535
Mol Pharmacol. 2007 Oct;72(4):921-33
pubmed: 17622576
Cell. 2007 Nov 2;131(3):596-610
pubmed: 17981125
Cancer Res. 2007 Dec 1;67(23):11166-75
pubmed: 18056441
J Neural Transm (Vienna). 2008 Jun;115(6):899-908
pubmed: 18351286
Biochem J. 2008 Jun 1;412(2):191-209
pubmed: 18466116
J Biol Chem. 2008 Jul 11;283(28):19646-56
pubmed: 18467334
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4154-61
pubmed: 18469181
Ann Nucl Med. 2008 Apr;22(3):151-6
pubmed: 18498028
J Biol Chem. 2008 Oct 17;283(42):28198-215
pubmed: 18539593
Neurosci Lett. 2008 Jul 25;440(1):19-22
pubmed: 18547721
PLoS One. 2008 Jul 02;3(7):e2558
pubmed: 18596927
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4993-5002
pubmed: 18641291
J Pharmacol Exp Ther. 2008 Nov;327(2):491-502
pubmed: 18723775
Behav Brain Res. 2009 Mar 17;198(2):472-6
pubmed: 19100292
J Neurosci. 2009 Feb 4;29(5):1257-66
pubmed: 19193873
J Neurochem. 2009 May;109(3):744-54
pubmed: 19245662
Am J Physiol Cell Physiol. 2009 May;296(5):C1049-57
pubmed: 19279232
J Mol Cell Cardiol. 2009 Jun;46(6):789-803
pubmed: 19285504
J Neurochem. 2009 Aug;110(4):1129-34
pubmed: 19457065
Biochim Biophys Acta. 2009 Nov;1787(11):1395-401
pubmed: 19576166
Structure. 2009 Sep 9;17(9):1205-12
pubmed: 19748341
J Pharmacol Exp Ther. 2010 Feb;332(2):388-97
pubmed: 19855099
Eur J Pharmacol. 2010 Feb 25;628(1-3):19-26
pubmed: 19919834
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22468-73
pubmed: 20018732
Mol Pharmacol. 2010 Apr;77(4):695-703
pubmed: 20089882
Neuroscience. 2010 May 5;167(2):247-55
pubmed: 20167253
Biophys J. 2010 Apr 7;98(7):1182-91
pubmed: 20371317
Hum Psychopharmacol. 2010 Apr;25(3):193-200
pubmed: 20373470
J Neurosci. 2010 Jun 23;30(25):8566-80
pubmed: 20573903
Clin Neuropharmacol. 2010 Sep-Oct;33(5):260-4
pubmed: 20616707
Eur J Pharmacol. 2010 Oct 10;644(1-3):88-95
pubmed: 20667452
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18676-81
pubmed: 20956312
Ann Neurol. 2010 Nov;68(5):639-49
pubmed: 21031579
J Neurosci. 2010 Nov 3;30(44):14708-18
pubmed: 21048129
Am J Physiol Cell Physiol. 2011 Feb;300(2):C328-37
pubmed: 21084640
Blood. 2011 Feb 24;117(8):2538-47
pubmed: 21148086
Brain. 2011 Mar;134(Pt 3):732-46
pubmed: 21278085
J Clin Invest. 2011 Feb;121(2):493-9
pubmed: 21285522
J Neurochem. 2011 Jun;117(5):879-91
pubmed: 21434925
Brain Res Bull. 2011 May 30;85(3-4):219-24
pubmed: 21453760
Mol Vis. 2011 Apr 26;17:1034-43
pubmed: 21541278
Clin Neuropharmacol. 2011 May-Jun;34(3):95-100
pubmed: 21586914
Curr Alzheimer Res. 2011 Nov;8(7):765-70
pubmed: 21605063
Eur J Pharmacol. 1990 Apr 25;179(3):441-5
pubmed: 2163857
Eur J Pharmacol. 1990 Apr 25;188(4-5):211-8
pubmed: 2163873
J Biol Chem. 2011 Aug 12;286(32):27947-58
pubmed: 21680736
Chem Biol. 2011 Jun 24;18(6):777-93
pubmed: 21700213
Am J Pathol. 2011 Aug;179(2):980-91
pubmed: 21704011
Ann Neurol. 2011 Dec;70(6):913-9
pubmed: 21842496
Invest Ophthalmol Vis Sci. 2011 Sep 29;52(10):7749-60
pubmed: 21862648
Synapse. 2012 Jan;66(1):42-51
pubmed: 21905129
Lancet Neurol. 2011 Dec;10(12):1049-57
pubmed: 22071279
Synapse. 2012 Jul;66(7):630-9
pubmed: 22337473
Mol Psychiatry. 2013 Jan;18(1):12-4
pubmed: 22349783
Brain Res. 2012 May 3;1452:1-9
pubmed: 22433979
Neurosci Lett. 2012 May 31;517(2):136-9
pubmed: 22561649
Biochemistry. 2012 Aug 14;51(32):6266-88
pubmed: 22783824
J Pharmacol Exp Ther. 2012 Dec;343(3):578-86
pubmed: 22923735
Neurotherapeutics. 2012 Oct;9(4):814-26
pubmed: 22935988
J Biol Chem. 2012 Oct 26;287(44):37021-9
pubmed: 22952230
PLoS One. 2012;7(9):e45118
pubmed: 23028794
Trends Neurosci. 2012 Dec;35(12):762-71
pubmed: 23102998
J Biol Chem. 2012 Dec 14;287(51):43156-69
pubmed: 23105111
PLoS One. 2012;7(11):e49384
pubmed: 23139844
Exp Eye Res. 2013 Feb;107:21-31
pubmed: 23183135
Mol Vis. 2012;18:2860-70
pubmed: 23233788
PLoS One. 2012;7(12):e51910
pubmed: 23284812
Mol Pharmacol. 2013 Mar;83(3):577-86
pubmed: 23295385
Biochemistry. 2013 Feb 5;52(5):859-68
pubmed: 23324054
Cell. 2013 Jan 17;152(1-2):236-47
pubmed: 23332758
Mov Disord. 2013 Sep;28(10):1407-15
pubmed: 23450660
Neuroscience. 2013 Jun 14;240:129-34
pubmed: 23458708
J Neural Transm (Vienna). 2013 Sep;120(9):1281-94
pubmed: 23468085
Neuropsychopharmacology. 2013 Aug;38(9):1706-23
pubmed: 23493042
PLoS One. 2013 Apr 08;8(4):e60863
pubmed: 23593332
PLoS One. 2013 Apr 18;8(4):e61245
pubmed: 23637801
Cell Death Dis. 2013 May 23;4:e646
pubmed: 23703391
J Biol Chem. 2013 Jul 19;288(29):21448-57
pubmed: 23760505
PLoS One. 2013 Oct 08;8(10):e75760
pubmed: 24116072
Neurobiol Dis. 2014 Feb;62:218-32
pubmed: 24141020
PLoS One. 2013 Oct 18;8(10):e76941
pubmed: 24204710
Nat Commun. 2013;4:2753
pubmed: 24217578
Neuropathology. 2014 Apr;34(2):148-58
pubmed: 24313828
Neurosci Lett. 2014 Jan 24;559:174-8
pubmed: 24334165
Int J Neuropsychopharmacol. 2014 Dec;17(12):1943-55
pubmed: 24485144
J Neurosci. 2014 Mar 5;34(10):3545-58
pubmed: 24599455
J Biol Chem. 2014 Apr 18;289(16):11111-21
pubmed: 24616099
Neurobiol Aging. 2014 Aug;35(8):1957.e7-8
pubmed: 24684794
Neuron. 2014 Apr 2;82(1):79-93
pubmed: 24698269
Neuroreport. 2014 Jul 9;25(10):731-6
pubmed: 24709917
Brain. 2014 Jul;137(Pt 7):1998-2014
pubmed: 24755275
J Biol Chem. 2014 Jul 18;289(29):20333-44
pubmed: 24847081
ACS Med Chem Lett. 2011 Aug 27;2(11):834-9
pubmed: 24900272
J Alzheimers Dis. 2015;43(2):369-74
pubmed: 25096627
J Neurosci. 2014 Aug 20;34(34):11325-38
pubmed: 25143613
J Biol Chem. 2014 Nov 14;289(46):32353-63
pubmed: 25266722
Stroke. 2014 Nov;45(11):3304-10
pubmed: 25270629
J Huntingtons Dis. 2014;3(3):285-98
pubmed: 25300332
Neurobiol Dis. 2015 Feb;74:25-31
pubmed: 25449906
Biochem J. 2015 Mar 1;466(2):263-271
pubmed: 25510962
FEBS Lett. 2015 Feb 27;589(5):659-65
pubmed: 25647032
Neurosci Lett. 2015 Mar 30;591:13-8
pubmed: 25666889
Brain. 2015 Apr;138(Pt 4):875-90
pubmed: 25678561
J Pharmacol Sci. 2015 Jan;127(1):10-6
pubmed: 25704013
Free Radic Biol Med. 2015 Sep;86:25-36
pubmed: 25920363
BMC Biochem. 2015 Apr 30;16:11
pubmed: 25924612
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6742-7
pubmed: 25964330
Eur Neuropsychopharmacol. 2015 Aug;25(8):1275-86
pubmed: 25983018
Sci Rep. 2015 Jun 02;5:10689
pubmed: 26033680
Neurology. 2015 Jun 16;84(24):2430-7
pubmed: 26078401
J Cell Mol Med. 2015 Nov;19(11):2540-8
pubmed: 26094900
Psychopharmacology (Berl). 2015 Sep;232(18):3443-53
pubmed: 26159455
Neurogenetics. 2015 Oct;16(4):299-306
pubmed: 26205306
Cell Mol Neurobiol. 2016 Jul;36(5):639-45
pubmed: 26228028
Mol Neurodegener. 2015 Aug 15;10:37
pubmed: 26275606
Nature. 2015 Sep 17;525(7569):333-8
pubmed: 26352471
J Neurosci. 2015 Sep 30;35(39):13275-86
pubmed: 26424877
Biochem J. 2016 Jan 1;473(1):1-5
pubmed: 26467159
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6562-70
pubmed: 26554014
Neuron. 2015 Nov 18;88(4):667-77
pubmed: 26590344
Neurodegener Dis. 2016;16(1-2):95-110
pubmed: 26606130
J Neurosci. 2016 Jan 6;36(1):125-41
pubmed: 26740655
CNS Neurosci Ther. 2016 May;22(5):368-77
pubmed: 26854125
Trends Pharmacol Sci. 2016 Apr;37(4):262-278
pubmed: 26869505
Nature. 2016 Apr 28;532(7600):527-30
pubmed: 27042935
J Cell Biol. 2016 Apr 11;213(1):65-79
pubmed: 27069021
Hum Mol Genet. 2016 Sep 1;25(17):3741-3753
pubmed: 27402882
Hum Mol Genet. 2016 Sep 15;25(18):3975-3987
pubmed: 27466197
EXCLI J. 2012 Aug 27;11:517-30
pubmed: 27540345
Neurology. 2016 Oct 11;87(15):1607-1612
pubmed: 27629094
Cell Death Dis. 2016 Oct 13;7(10):e2414
pubmed: 27735948
Neurobiol Dis. 2017 Jan;97(Pt A):46-59
pubmed: 27818324
EMBO Mol Med. 2016 Dec 1;8(12):1421-1437
pubmed: 27821430
J Neurosci. 2016 Nov 23;36(47):11837-11850
pubmed: 27881772
Cancer Res. 2017 May 1;77(9):2439-2452
pubmed: 28235766
Handb Exp Pharmacol. 2017;244:81-108
pubmed: 28275911
J Biol Chem. 2017 Jul 7;292(27):11250-11261
pubmed: 28495886
Front Pharmacol. 2017 May 26;8:302
pubmed: 28603497
Biosci Rep. 2017 Jul 16;37(4):null
pubmed: 28667101
Nature. 1986 Feb 27-Mar 5;319(6056):774-6
pubmed: 2869411
Neurobiol Aging. 2017 Nov;59:171-183
pubmed: 28870519
Oxid Med Cell Longev. 2017;2017:4582135
pubmed: 28883901
J Biomed Sci. 2017 Sep 16;24(1):74
pubmed: 28917260
Protein Cell. 2018 Aug;9(8):733-737
pubmed: 28929457
Neurotox Res. 2019 Jan;35(1):1-18
pubmed: 29127580
Behav Brain Res. 2018 Feb 26;339:1-10
pubmed: 29129596
Bull Exp Biol Med. 2017 Dec;164(2):252-258
pubmed: 29177899
JCI Insight. 2017 Dec 7;2(23):
pubmed: 29212949
Sci Rep. 2017 Dec 15;7(1):17625
pubmed: 29247211
Nat Commun. 2017 Dec 20;8(1):2228
pubmed: 29263318
Alzheimers Dement. 2018 Jun;14(6):811-823
pubmed: 29291374
Neuropharmacology. 2018 May 1;133:264-275
pubmed: 29407216
J Huntingtons Dis. 2018;7(1):35-50
pubmed: 29480205
J Huntingtons Dis. 2018;7(1):1-16
pubmed: 29480206
Mol Neurodegener. 2018 May 21;13(1):25
pubmed: 29783994
Mol Psychiatry. 2018 Jun 7;:null
pubmed: 29880884
J Neurosci. 1986 Jun;6(6):1757-70
pubmed: 3012017
Nat Struct Mol Biol. 2018 Oct;25(10):981-987
pubmed: 30291362
Lancet Neurol. 2019 Feb;18(2):165-176
pubmed: 30563778
Neurobiol Dis. 2019 Apr;124:489-504
pubmed: 30594810
Neurotherapeutics. 2019 Apr;16(2):465-479
pubmed: 30756361
Cell Death Dis. 2019 Mar 1;10(3):210
pubmed: 30824685
Sci Transl Med. 2019 Mar 27;11(485):
pubmed: 30918112
Front Pharmacol. 2019 Mar 19;10:223
pubmed: 30941035
Pharmacol Res. 2019 Jun;144:315-330
pubmed: 31048034
Neurobiol Dis. 2019 Sep;129:118-129
pubmed: 31108174
Front Cell Neurosci. 2019 May 16;13:209
pubmed: 31156395
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3774-8
pubmed: 7731982
J Pharmacol Exp Ther. 1994 Oct;271(1):212-9
pubmed: 7965717
Brain Res. 1993 Oct 1;623(2):299-302
pubmed: 8221112
Br J Pharmacol. 1995 Dec;116(7):2801-10
pubmed: 8680709
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8072-7
pubmed: 8755605
Eur J Pharmacol. 1996 Jun 13;306(1-3):271-9
pubmed: 8813641
Biochem Biophys Res Commun. 1996 Dec 13;229(2):553-8
pubmed: 8954936
Prog Neuropsychopharmacol Biol Psychiatry. 1997 Jan;21(1):69-102
pubmed: 9075259
Neurochem Int. 1998 Apr;32(4):337-43
pubmed: 9596556
Nat Med. 1999 Jan;5(1):101-6
pubmed: 9883847